Sclerosis: Clinical Trials

9 trials for Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 2 unknown, 1 enrolling by invitation. 9 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 4, Recruiting 2, Unknown 2, Enrolling by invitation 1

Follow Sclerosis: new trials by email Literature Review of Sclerosis trials Research Report on Sclerosis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis
Diosmin, Placebo - Scleroderma, Systemic, Digital Ulcer
Not applicableRecruitingPrimus Pharmaceuticals452025-05-022026-11-10
Effects of Individualized Training to Reduce Fatigue in Patients With Newly and Advanced Diagnosed Multiple Sclerosis
Traditional exercise, Individualized exercise - Sclerosis, Fatigue
Not applicableRecruitingCentre Hospitalier Universitaire de Saint Etienne962023-09-122024-10-23
Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple Sclerosis
Standard Exercise Training, Phoenix Exoskeleton suit - Multiple Sclerosis, Pathologic Processes
Not applicableCompletedSheffield Teaching Hospitals NHS Foundation Trust242022-06-232026-05-19
Magnetic Imaging for Diagnostic of Amyotrophic Lateral Sclerosis
Whole Body MRI and ENMG - Amyotrophic Lateral Sclerosis With Dementia
Not applicableUnknownUniversity Hospital, Toulouse502021-06-012024-08-02
Aerobic Exercise for Remyelination in Multiple Sclerosis
Aerobic exercise, Education Group Control - Multiple Sclerosis, Sclerosis
Not applicableCompletedOregon Health and Science University602021-04-292026-09-23
Power Training in Older Multiple Sclerosis Patients
Power training - Multiple Sclerosis, Sclerosis
Not applicableUnknownUniversity of Aarhus602020-12-072023-06-23
Assessment of Language Disorders in Multiple Sclerosis Patients
Case, Withness - Sclerosis, Language Disorders
Not applicableCompletedFondation Ophtalmologique Adolphe de Rothschild1422020-08-172023-02-15
Behavior and Activity Monitoring in MS
Step Tracking, Water Tracking - Relapsing-Remitting Multiple Sclerosis
Not applicableCompletedOhio State University872017-11-022023-03-24
Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis
N-acetyl Cysteine - Multiple Sclerosis
Not applicableEnrolling by invitationThomas Jefferson University552017-01-052025-09-17

Narrower conditions

Multiple Sclerosis (5)  ·  Autoimmune Diseases of the Nervous System (4)  ·  Demyelinating Autoimmune Diseases, CNS (4)  ·  Demyelinating Diseases (3)  ·  Motor Activity (3)  ·  Nervous System Diseases (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Autoimmune Diseases (1)  ·  Fatigue (1)  ·  Immune System Diseases (1)  ·  Language Disorders (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Neurodegenerative Diseases (1)  ·  Pathologic Processes (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (9)  ·  Pathologic Processes (8)  ·  Central Nervous System Diseases (5)  ·  Nervous System Diseases (5)  ·  Autoimmune Diseases (4)  ·  Brain Diseases (4)  ·  Immune System Diseases (4)  ·  Leukoencephalopathies (4)  ·  Behavior (3)  ·  Demyelinating Diseases (2)  ·  Signs and Symptoms (2)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Communication Disorders (1)  ·  Connective Tissue Diseases (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)

Interventions

Acetylcysteine (1)  ·  Diosmin (1)  ·  Exercise (1)

Sponsors

Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Fondation Ophtalmologique Adolphe de Rothschild (1)  ·  Ohio State University (1)  ·  Oregon Health and Science University (1)  ·  Primus Pharmaceuticals (1)  ·  Sheffield Teaching Hospitals NHS Foundation Trust (1)  ·  Thomas Jefferson University (1)  ·  University Hospital, Toulouse (1)  ·  University of Aarhus (1)

Countries

France (3)  ·  United States (3)  ·  Canada (1)  ·  Denmark (1)  ·  United Kingdom (1)

Top investigators

Anouska Carter (1)  ·  Christine Smith (1)  ·  Daniel A Monti, MD, MBA (1)  ·  Krishnan Padmakumari Sivaraman Nair (1)  ·  Lindsey B Wooliscroft, MD (1)  ·  Ruchika S Prakash, PhD (1)  ·  Tobias Gaemelke, Msc (1)

Results publications

PMID 34309408, PMID 34377857, PMID 37690438, PMID 38444875, PMID 39207422, PMID 40966534

NIH funding

K23HD101667 (1), UL1TR002369 (1)